Search Results - "DeWall, Stephen L"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus by McKie, Elizabeth A, Reid, Juliet L, Mistry, Prafull C, DeWall, Stephen L, Abberley, Lee, Ambery, Philip D, Gil-Extremera, Blas

    Published in PloS one (01-03-2016)
    “…Evidence suggests that chronic subclinical inflammation plays an important role in the pathogenesis of type 2 diabetes (T2DM). Circulating levels of…”
    Get full text
    Journal Article
  2. 2

    Characterization of the robust humoral immune response to GSK2618960, a humanized anti-IL-7 receptor monoclonal antibody, observed in healthy subjects in a Phase 1 study by Liao, Karen, Chen, Keguan, Brett, Sara, Gehman, Andrew, Schwartz, Ann M, Gunn, George R, DeWall, Stephen L

    Published in PloS one (23-03-2021)
    “…Interleukin-7 (IL-7) signaling modulates T cell activity and is implicated in numerous autoimmune diseases. An anti-IL-7 receptor monoclonal antibody…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Immunogenicity Risk Assessment for PEGylated Therapeutics by Mora, Johanna R., White, Joleen T., DeWall, Stephen L.

    Published in The AAPS journal (28-01-2020)
    “…The objective of this manuscript is to provide the reader with two examples on how to present an immunogenicity risk assessment for a PEGylated therapeutic as…”
    Get full text
    Journal Article
  5. 5

    False-positive immunogenicity responses are caused by CD20+ B cell membrane fragments in an anti-ofatumumab antibody bridging assay by Chen, Keguan, Page, Jerry G., Schwartz, Ann M., Lee, Thomas N., DeWall, Stephen L., Sikkema, Daniel J., Wang, Catherine

    Published in Journal of immunological methods (30-08-2013)
    “…An electrochemiluminescent (ECL) bridging assay to detect anti-ofatumumab antibodies (ADA) in human serum samples was developed and validated. Using this assay…”
    Get full text
    Journal Article
  6. 6

    A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus: e0150018 by McKie, Elizabeth A, Reid, Juliet L, Mistry, Prafull C, DeWall, Stephen L, Abberley, Lee, Ambery, Philip D, Gil-Extremera, Blas

    Published in PloS one (01-03-2016)
    “…Objective Evidence suggests that chronic subclinical inflammation plays an important role in the pathogenesis of type 2 diabetes (T2DM). Circulating levels of…”
    Get full text
    Journal Article
  7. 7

    Steroidal Aza-Lariat Ethers: Syntheses and Aggregation Behavior by Nakano, Akio, Hernandez, Jeanette C., Dewall, Stephen L., Wang, Keshi, Bergerc, Daniel R., Gokel, George W.

    Published in Supramolecular chemistry (01-05-1997)
    “…Ten steroid-substituted lariat ether compounds have been prepared including one- and two-armed derivatives of aza-15-crown-5 and aza- and diaza-18-crown-6…”
    Get full text
    Journal Article